Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Search

Astellas Pharma Inc.

  • About
    • President and CEO’s Message
    • Philosophy
      • Charter of Corporate Conduct
    • Vision & Strategy
    • Governance
      • Group Code of Conduct
    • Corporate Information
      • Subsidiaries & Locations
      • Management
    • History
    • Board of Directors
    • Top Management
    • Product Introductions
    • Policies & Position Statements
    • Astellas at a Glance
    • Compliance Initiatives
    Recommended
    Astellas at a Glance

    Let us introduce our company in figures of FY2015 (as of March 31, 2016).

    Read More
  • Innovation
    • Therapeutic Areas
      • Oncology
      • Urology & Nephrology
      • Immunology
      • Neuroscience
      • New Areas
    • R&D
      • Approach
      • Ethics & Principles
      • Clinical Trials
      • Pipeline
    • Partnering
      • Track Record
      • Areas of Interest
      • Register Form
    Recommended
    Clinical Trials

    This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any produ...

    Read More
  • Responsibility
    • Our Commitment
    • Our CSR-Based Management
      • Materiality in CSR Activities
        • Enlarged image of CSR Materiality Matrix
      • ISO26000 and CSR-Based Management
      • United Nations Global Compact
    • Access to Health
      • Collaborative Research on a Rice-Based Oral Vaccine
      • Development of Pediatric Formulation for Schistosomiasis
      • Participation in Global Health Innovative Technology Fund (GHIT Fund)
      • Action on Fistula
      • SDGs
    • Access Accelerated
    • Stakeholder Communications
      • Peer Support Training Program (in Japan)
      • Communication with Patients (in U.S.)
      • Communication with the World Anti-Doping Agency (WADA)
      • Local Community Dialogue
    • Five Fields of CSR-Based Management
      • CSR Activities: Results and Plans
      • Five Fields of CSR-Based Management Diagram
    • Business Activities
      • Responsible Business Activities
      • With our Business Partners
        • Basic policy for procurement activities involving suppliers
      • UK Modern Slavery Act
    • Society
      • Priority Areas of Astellas Domestic Social Contribution Activities
      • 1st priority
        • Information Service
      • 2nd priority
      • 3rd priority
        • Changing Tomorrow Day
        • Flying Star Fund (Japan)
        • Donation of wheelchair vans in Japan
        • Donation of Ambulances in Japan
        • Disaster Relief Activities
      • Astellas Foundation
    • Environment
      • Definition of terms
      • Environmental Action Plan
        • Detailed breakdown data
      • Environment Management
        • Status of obtaining ISO 14001 Certification
        • Astellas Environment, Health & Safety Guidelines
      • Climate Change Mitigation Measures
        • Our Efforts to Reduce GHG Emissions
        • Breakdown of Scope 1 and Scope 2 for GHG Emissions
        • Enlarged image of GHG emissions from supply chain
        • Assumptions used to estimate GHG emissions (Scope 3)
      • Breakdown of Energy Consumption
        • Details of Energy consumption
      • Preserving Biodiversity
        • Biodiversity and Astellas An enlarged version
        • The Biodiversity Index calculation method
        • The Biodiversity Burden Index and Sales
      • Cyclic Use of Resources
        • Details of wastes
      • Pollution Prevention etc.
        • Further information on PRTR system
      • Environmental Impact of Products and Countermeasures
      • Environmental Accounting
        • Environment-related Investments and Expenses
      • Reporting coverage, methods, etc.
        • Calculation Method for Scope 3 Emissions
      • Environmental Report
      • Independent Assurance Report
    • EMPLOYEES
      • Development and Training
      • Workplace
      • Human Rights / OSH
      • Data
        • Major Programs (Japan)
    • Ethics & Compliance
    Recommended
    Access Accelerated

    Astellas participates in Access Accelerated. Access Accelerated is a first-of-its-kind, multi-stakeholder collaboration focused on improving...

    Read More
  • News
    • News
    • Stories
    • Media Contacts
    Recommended
    Stories

    The “Story” section contains contents focused on “hero”: people (patients, employees, scientists, etc.), scientific innovation and social im...

    Read More

Stakeholders menu

  • Investors
    • Financial Information
      • Financial Data (Annual Data)
      • Financial Data (Quarterly Data)
      • Financial Statements
      • Sale of Major Products
      • Geographical Segment Information
    • IR Library
    • IR Calendar
    • Stock & Rating Information
      • Shareholder's Meeting
      • Shareholder Return
      • Current Share Status
      • Chart
      • Ratings
    • Cautionary Statement
    • Analyst Coverage
  • Contact Us

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  • JAPAN
  • WORLDWIDE - Japan
  • 日本語
  • English

Breadcrumb

  1. Home
  2. Investors
Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

I Agree
logo
Thank you for visiting the Astellas Pharma Inc. Website.
You will enter external sites beyond here.
(This link opens in a new window)
Cancel Click here to leave this site.

Investor Relations

Investors
Investors

Stock Quotes(TSE 1st:4503)

View Stock Performance

IR News

Jan 31, 2018
Astellas Reports Financial Results for the First Nine Months of FY2017
Jan 10, 2018
Posted Presentation Slides for Conference Hosted by J.P. Morgan
Dec 14, 2017
Updated "Astellas Investor Meeting" Section
Oct 31, 2017
Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year Outlook
Oct 31, 2017
Posted Financial Results for 2Q/FY2017
Oct 31, 2017
Updated "IR Calendar" Section
View All >>

Latest Materials

Financial Results (pdf 262KB)
Supplementary Documents (pdf 506KB)
Overview of R&D Pipeline (pdf 93KB)
Presentation Material for Information Meeting (pdf 585KB) (January 31, 2018)

On-demand Replay of Information Meeting

View All >>

Financial Information

Review our consolidated business results, forecasts and financial data, etc.

Read More
IR Library

This section contains IR related information for shareholders and investors. Various IR materials can be downloaded from here.

Read More
IR Calendar

Find our upcoming IR events.

Read More
Stock & Rating Information

Year-end dividend - March 31 Interim dividend - September 30 Note: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment.

Read More
Analyst Coverage

List of analysts of securities companies and research companies who make recommendations and reports of Astellas' performance, etc

Read More
Cautionary Statement

The information disclosed in this part of the Astellas Website is provided for better understanding of Astellas by stakeholders including shareholders and investors, but is intended to neither solicit nor recommend the purchase of the Astellas's stock.

Read More
Corporate Information

Let us introduce our company profile, such as company name, capital and office locations.

Read More
Vision & Strategy

On the forefront of healthcare change to turn innovative science into value for patients.

Read More
Pipeline

We introduce the progress of our clinical development projects called "R&D pipeline". We update R&D pipeline 4 or 5 times annually in our quarterly performance reports.

Read More

Follow us on social media

Facebook icon Youtube icon

Main navigation

  • About
    • President and CEO’s Message
    • Philosophy
    • Vision & Strategy
    • Governance
    • Corporate Information
    • History
    • Board of Directors
    • Top Management
    • Product Introductions
    • Policies & Position Statements
    • Astellas at a Glance
    • Compliance Initiatives
  • Innovation
    • Therapeutic Areas
    • R&D
    • Partnering
  • Responsibility
    • Our Commitment
    • Our CSR-Based Management
    • Access to Health
    • Access Accelerated
    • Stakeholder Communications
    • Five Fields of CSR-Based Management
    • Business Activities
    • Society
    • Environment
    • EMPLOYEES
    • Ethics & Compliance
  • News
    • News
    • Stories
    • Media Contacts

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • ACCESSIBILITY
  • TERMS OF USE
  • CONTACT US
Copyright © 2018 Astellas Pharma Inc. All right Reserved.